The Quick Take
Purchase price matters. In a tight reimbursement environment, every penny on a purchase order counts. But purchase price is not the whole picture. With the average cost of capital sitting around 8.5%, every dollar of inventory on your shelves is quietly costing you more than most pharmacy operators realize. When you factor in rebates, net cost-of-goods, and how fast your inventory investment converts back to revenue, asset velocity becomes an equally critical margin lever. A pharmacy turning inventory 24 times a year is freeing working capital and protecting profitability in ways a pharmacy turning 13 times simply cannot replicate, even if both are buying from the same wholesaler at the same price.
Why Are We Talking About Inventory When Reimbursement Is This Tight?
Fair question. When DIR fees are compressing margins, specialty drug costs are climbing, and payer reimbursement rates are moving in the wrong direction, the instinct is to focus on what you can control: purchase price. Negotiate harder. Source smarter. Squeeze every basis point out of every line item.
That instinct is not wrong. But it is incomplete.
Purchase price optimization addresses one side of the margin equation: what you pay to acquire product. It does not address the other side: how long that product sits on your shelf before it generates revenue. And in a rising cost-of-capital environment, the shelf time is where margin quietly disappears.
What Does Cost of Capital Have to Do with Pharmacy Inventory?
The average cost of capital across industries currently sits around 8.5%. That number represents the real cost of money, what it costs your business to have dollars tied up in assets instead of working elsewhere.
For pharmacy operators, inventory is one of the largest capital-intensive assets in the business. Every bottle, every vial, every unit on your shelf represents dollars that are not available for payroll, debt service, expansion, or simply earning a return somewhere else. At 8.5%, the carrying cost of excess inventory is not theoretical. It is a real, measurable drag on your business.
Here is a simple way to think about it: if you have $500,000 in average inventory on hand and your cost of capital is 8.5%, you are paying roughly $42,500 a year just to hold that inventory. That number does not include obsolescence, expiration, shrink, or the opportunity cost of capital deployed elsewhere. It is purely the cost of money sitting on shelves.
Now multiply that across a multi-store operation, a cooperative group, or an LTC pharmacy managing duplicated inventory across dispensing, compliance packaging, and emergency kits. The carrying cost compounds quickly, and most pharmacy operators are not tracking it as a distinct financial metric.
What Is Asset Velocity, and Why Does It Matter More in 2026?
Asset velocity is the rate at which your inventory investment converts back into revenue. In simpler terms: how fast are you turning your inventory dollars into cash?
A pharmacy achieving 24 inventory turns per year is converting its entire inventory investment into revenue roughly every 15 days. A pharmacy achieving 13 turns is taking nearly 28 days. That 13-day difference is not just an operational metric. It is a financial one.
At 24 turns, capital is cycling back into the business faster. There is less money trapped in product that has not yet been dispensed. There is less exposure to expiration on high-cost items. There is more flexibility to succeed despite reimbursement pressure because working capital is not locked up on the shelf.
At 13 turns, the opposite is true. More capital is tied up for longer. The margin for error on every stocking decision is smaller. And the cost of holding that inventory, at 8.5% cost of capital, is eating into whatever purchase price savings you negotiated on the front end.
The operators who are winning in 2026 are not just buying smarter. They are turning faster.
How Does Net Cost-of-Goods Change the Sourcing Math?
Most pharmacy management systems calculate cost-of-goods based on the purchase price at the time of acquisition. That is the number pharmacy operators typically use to evaluate whether they got a good deal. But it is not the real number.
The real number is net cost-of-goods, inclusive of rebates, incentives, and contract performance adjustments. Your purchasing contracts have performance levers that directly inform buying rules, and those levers only work in your favor when your purchasing decisions are aligned with them in real time. Without that alignment, the “cheaper” option on a per-unit basis is often the more expensive option on a net-cost basis.
But net cost is only part of the equation. The best buying opportunities do not always arrive on a schedule. Without a system that integrates real-time rebate data and contract logic into purchasing decisions, pharmacy operators are making complex sourcing decisions in the dark, and often missing their best buy windows entirely because the timing was wrong, not the deal.
By calculating the true landed cost after all adjustments, intelligent inventory platforms ensure pharmacies are capturing their peak primary rebates, optimizing for true margin rather than just an upfront sticker price.
Why Inventory Velocity Is a Financial Strategy, Not Just an Operational Metric
Pharmacy operators have traditionally thought about inventory turns as an operational KPI: something the inventory manager tracks and the executive team reviews quarterly. But in a market defined by margin compression, rising cost of capital, and increasing SKU complexity, inventory velocity has become a financial strategy.
Faster turns free working capital. That capital can be deployed toward growth, debt reduction, or simply building a cash buffer against reimbursement volatility. Faster turns reduce exposure to expiration on high-cost items like GLP-1s and specialty medications, where a single expired unit can mean a $1,000 write-off. Faster turns improve PDC (proportion of days covered) scores by ensuring the right product is on the shelf when the patient needs it, which protects reimbursement performance downstream.
The connection between velocity and margin resilience is direct. The pharmacies that will weather the next wave of reimbursement pressure are not the ones that bought cheapest. They are the ones that moved fastest.
The OrderInsite Perspective
OrderInsite helps pharmacy operators see the full picture: not just what they paid for inventory, but how fast that inventory is converting to revenue, where capital is trapped in overstock or dead inventory, and how net cost-of-goods inclusive of rebates changes the sourcing math.
Our platform integrates purchasing intelligence, demand forecasting, and real-time inventory visibility across locations, so operators can make stocking decisions based on actual margin impact, not just sticker price. For multi-store operators and cooperative groups, that visibility extends across the entire network, regardless of underlying pharmacy management systems.
The goal is not to replace the focus on purchase price. It is to expand the lens so pharmacy operators are managing the full cost of inventory ownership, from acquisition through dispensing, with the same rigor they apply to purchasing negotiations.
Key Takeaways
- Cost of capital is a real inventory cost: At 8.5%, excess inventory is more expensive to hold than most pharmacy operators realize
- Asset velocity is a margin lever: The difference between 24 turns and 13 turns is not just operational; it is financial
- Purchase price is necessary but insufficient: Without factoring in rebates, net cost-of-goods, and turn rates, sourcing decisions are based on incomplete data
- Net cost-of-goods changes the math: The cheapest purchase price is not always the best margin outcome
- Velocity protects against volatility: Faster turns reduce exposure to expiration, reimbursement pressure, and working capital constraints
FAQ
Q: Is this saying purchase price doesn’t matter?
A: No. Purchase price absolutely matters, especially in a tight reimbursement environment. The point is that purchase price alone does not tell the full story. When you add cost of capital, carrying costs, and net cost-of-goods to the equation, asset velocity becomes an equally important variable in protecting margin.
Q: What is a good inventory turn rate for a pharmacy?
A: It varies by pharmacy type and size, but pharmacies using OrderInsite consistently achieve 18-24+ turns per year. While the industry average for independent pharmacies sits around 10-12 turns, pharmacies actively optimizing for velocity consistently reach the higher end of that range and beyond.
Q: How does this apply to LTC pharmacies?
A: LTC pharmacies often carry duplicated inventory across active dispensing, compliance packaging, specialty packaging lines, and emergency kits at facilities. The carrying cost impact is amplified because the same product may be sitting in multiple positions across the operation. Velocity improvements in LTC require visibility across all of those inventory positions, not just the central dispensing stock.
Q: How does OrderInsite calculate net cost-of-goods?
A: OrderInsite integrates rebate and contract performance data into purchasing logic, so operators can see the true landed cost of every product, not just the sticker price at the time of purchase. This helps pharmacies make sourcing decisions based on actual margin impact rather than incomplete cost data.
What to Do Next
Start by asking a simple question: do you actually trust your inventory numbers? Can you see what you have, where it is, and how fast it’s moving? If the answer is uncertain, there is capital on your shelves that is working against you.
Talk to an OrderInsite team member to get a clear picture of where your inventory stands and where the opportunity is.
